177 related articles for article (PubMed ID: 12207636)
41. [Antidepressants: TCA versus SSRI versus other new agents].
Hay F; Linkowski P
Rev Med Brux; 2004 Sep; 25(4):A315-20. PubMed ID: 15516063
[TBL] [Abstract][Full Text] [Related]
42. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared.
Lawrenson RA; Tyrer F; Newson RB; Farmer RD
J Affect Disord; 2000 Aug; 59(2):149-57. PubMed ID: 10837883
[TBL] [Abstract][Full Text] [Related]
43. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.
Tata LJ; West J; Smith C; Farrington P; Card T; Smeeth L; Hubbard R
Heart; 2005 Apr; 91(4):465-71. PubMed ID: 15772201
[TBL] [Abstract][Full Text] [Related]
44. [Mirtazapine versus other antidepressive agents for depression].
Knud Larsen J
Ugeskr Laeger; 2012 Nov; 174(46):2864-6. PubMed ID: 23153468
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.
MacGillivray S; Arroll B; Hatcher S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
BMJ; 2003 May; 326(7397):1014. PubMed ID: 12742924
[TBL] [Abstract][Full Text] [Related]
46. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.
Zohar J; Westenberg HG
Acta Psychiatr Scand Suppl; 2000; 403():39-49. PubMed ID: 11019934
[TBL] [Abstract][Full Text] [Related]
47. [Hallucinations caused by paroxetine taken together with a levodopa-carbidopa preparation].
Schölzel-Dorenbos CJ
Ned Tijdschr Geneeskd; 2002 Aug; 146(35):1663-4. PubMed ID: 12233164
[No Abstract] [Full Text] [Related]
48. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.
Diem SJ; Blackwell TL; Stone KL; Yaffe K; Haney EM; Bliziotes MM; Ensrud KE
Arch Intern Med; 2007 Jun; 167(12):1240-5. PubMed ID: 17592096
[TBL] [Abstract][Full Text] [Related]
49. Antidepressants and colorectal cancer: A population-based nested case-control study.
Lee HC; Chiu WC; Wang TN; Liao YT; Chien IC; Lee Y; McIntyre RS; Chen PC; Chen VC
J Affect Disord; 2017 Jan; 207():353-358. PubMed ID: 27744223
[TBL] [Abstract][Full Text] [Related]
50. Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.
Gray R; Patel S; Ives N; Rick C; Woolley R; Muzerengi S; Gray A; Jenkinson C; McIntosh E; Wheatley K; Williams A; Clarke CE;
JAMA Neurol; 2022 Feb; 79(2):131-140. PubMed ID: 34962574
[TBL] [Abstract][Full Text] [Related]
51. L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo.
Miguelez C; Navailles S; Delaville C; Marquis L; Lagière M; Benazzouz A; Ugedo L; De Deurwaerdère P
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1297-309. PubMed ID: 27234917
[TBL] [Abstract][Full Text] [Related]
52. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
KoKoAung E; Cavenett S; McArthur A; Aromataris E
JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
[TBL] [Abstract][Full Text] [Related]
53. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2000; (4):CD002791. PubMed ID: 11034764
[TBL] [Abstract][Full Text] [Related]
54. GPs' perceptions of tolerability of selective serotonin reuptake inhibitors and tricyclic antidepressants. Analysis should discriminate between newer and older tricyclic antidepressants.
Ali IM
BMJ; 1997 Aug; 315(7107):547-8. PubMed ID: 9329324
[No Abstract] [Full Text] [Related]
55. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
Sussman N; Ginsberg DL; Bikoff J
J Clin Psychiatry; 2001 Apr; 62(4):256-60. PubMed ID: 11379839
[TBL] [Abstract][Full Text] [Related]
56. Central levodopa influx and the clinical motor response to levodopa in patients with Parkinson disease complicated with motor fluctuations and dyskinesias.
López-Ariztegui N; Arévalo MA; de Ceballos ML; Grandas F
Clin Neuropharmacol; 2009; 32(6):321-5. PubMed ID: 19667975
[TBL] [Abstract][Full Text] [Related]
57. General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants.
Martin RM; Hilton SR; Kerry SM; Richards NM
BMJ; 1997 Mar; 314(7081):646-51. PubMed ID: 9066479
[TBL] [Abstract][Full Text] [Related]
58. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
[TBL] [Abstract][Full Text] [Related]
59. Influence of antidepressants on glycaemic control in patients with diabetes mellitus.
Knol MJ; Derijks HJ; Geerlings MI; Heerdink ER; Souverein PC; Gorter KJ; Grobbee DE; Egberts AC
Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):577-86. PubMed ID: 18449949
[TBL] [Abstract][Full Text] [Related]
60. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
